Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
Status:
Recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
Single center, prospective, Open label study of sleep, pruritus and circadian function
pre/post 12-weeks of dupilumab treatment in children 6-17 years old
Phase:
Phase 4
Details
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago